Filing Details
- Accession Number:
- 0001209191-13-047414
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-03 20:24:15
- Reporting Period:
- 2013-10-01
- Filing Date:
- 2013-10-03
- Accepted Time:
- 2013-10-03 20:24:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1206199 | G Daniel Welch | 3280 Bayshore Boulevard Brisbane CA 94005 | Chairman, Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-10-01 | 50,000 | $8.73 | 227,434 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-10-01 | 70,000 | $15.43 | 157,434 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-10-01 | 50,000 | $0.00 | 50,000 | $8.73 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 324,999 | 2017-06-08 | No | 4 | M | Direct |
Footnotes
- The transaction was made pursuant to the terms of the 10b5-1 plan in effect at the time of the transaction.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $15.3 to $15.61 per share. Full information on the numbers of shares sold at each sale price is available upon request.
- Fully exercisable.
Billionaire Hedge Funds
